摘要:
The invention provides new radiolabeled monoacylglycerol lipase (MAGL) inhibitors that are useful for medical imaging, such as positron-emission tomography (PET), single-photon emission computed tomography (SPECT) and/or autoradiography.
摘要:
The invention provides novel compounds having the general formula (I) wherein R 1 , R 2 and n are as described herein, compositions including the compounds and methods of using the compounds.
摘要:
The invention provides novel compounds having the general formula (I) wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 , R 12 , A 1 and n are as described herein, compositions including the compounds and methods of using the compounds.
摘要:
The invention provides novel compounds having the general formula (I) (I) wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 , R 12 , R 13 , R 14 , R 15 , A, m, n and p described herein, compositions including the compounds and methods of using the compounds.
摘要:
The invention provides novel compounds having the general formula (1) wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 9 , R 10 , R 11 and A are as described herein, compositions including the compounds and methods of using the compounds. The compounds of formula (I) are useful as aldosterone synthase (CYP11B2 or CYP11B1) inhibitors for the treatment of various disorders.
摘要:
The invention provides new heterocyclic compounds having the general formula (I), wherein A, B, X, and R1 to R7 are as described herein, compositions including thecompounds, processes of manufacturing the compounds and methods of using the compounds.
摘要:
The invention provides new heterocyclic compounds having the general formula (I) wherein A, B, L1, X, m, n, and R1 to R7 are as described herein, compositions including the compounds, processes of manufacturing the compounds and methods of using the compounds as monoacylglycerol lipase (MAGL) inhibitors.
摘要:
The invention provides new heterocyclic compounds having the general formula (Ic) wherein A, L, X, m, n and R 20 to R 23 are as described herein, compositions including the compounds, processes of manufacturing the compounds and methods of using the compounds.
摘要:
The invention provides new heterocyclic compounds having the general formula (I) wherein A, L, X, m, n, R 1 , R 2 and R 3 are as described herein, pharmaceutically acceptable salts thereof, compositions including the compounds, processes of manufacturing the compounds and methods of using the compounds.
摘要:
The invention provides novel compounds having the general formula (I) wherein wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 3 , R 8 , R 9 , R 10 , R 11 , R 12 and R 23 are as described herein, compositions including the compounds and methods of using the compounds.